You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
A new government steering committee report outlines Hong Kong's plans for genomic medicine, the South China Morning Post reports.
In Science this week: genetic history of individuals from northern and southern East Asia, and more.
The Economist reports on an approach used by UK researchers to study medical records while protecting patient privacy.
The Telegraph reports Public Health England has approved a coronavirus antibody test.
According to CNBC, Atul Gawande has stepped down as the chief executive of Haven.
In Nature this week: missense variant linked to decreased height among Peruvians, genetic basis of sex-biased vulnerability to certain disorders, and more.
A Nature editorial calls for large, collaborative studies of potential COVID-19 treatments.
According to Retraction Watch, a US federal judge has ruled against Ohio State University professor Carlo Croce in a defamation case he brought.
A UK consortium aims to sequence COVID-19 patients to uncover genetic variants that may contribute to disease susceptibility or severity.
In Nucleic Acids Research this week: tool to track co-expression networks, tool to prioritize variants in rare diseases, and more.
According to ScienceInsider, the JASON advisory group is looking into how to best open university labs during the pandemic.
The US has warned research firms and others working on the response to COVID-19 that hackers may target them, NPR reports.
A University of Arkansas professor has been charged in connection with his alleged failure to disclose ties to the Chinese government in a grant application, the Associated Press says.
In PNAS this week: concerns regarding proposed SARS-CoV-2 phylogenetic network, adaptations that help Enterococcus establish infections, and more.
The UK has had to send samples to the US for coronavirus testing, according to the Telegraph.
The US Food and Drug Administration has issued an Emergency Use Authorization for Quidel's antigen test for SARS-CoV-2, 360Dx reports.
The New York Times reports that a federal watchdog group has recommended Rick Bright be reinstated to his former post during its investigation of his whistleblower claims.
In PLOS this week: sequencing-based way to uncover drug resistance in tuberculosis bacteria, genetic population structure of mosquito vectors, and more.
According to the New York Times, Paul Marks, the former president and chief executive of Memorial Sloan Kettering Cancer Center, has died at 93.
As GenomeWeb reports, the Food and Drug Administration has issued an Emergency Use Authorization for a CRISPR-based test for SARS-CoV-2.
According to Mongabay, researchers are using genetics to trace the origins of shark fins found for sale.
In Science this week: mass spectrometric analysis of the SARS-CoV-2 spike protein, and more.
The Economist discusses the effect of the COVID-19 pandemic on how scientific research is communicated.
Researchers are wondering how the COVID-19 pandemic may affect results from clinical trials that continued and how to account for that influence, ScienceInsider reports.
NPR reports the US was behind on its payments to the World Health Organization when President Trump announced he'd be cutting off funding.
New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.
A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.
Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.
In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.